On the other hand, the neuroprotective effects of TAK inhibition for stroke, traumatic brain injury and neurodegenerative diseases are associated with a reduced activation of JNK that leads to inflammation and apoptosis [46–48]. The gene discussed is MAPK8; the disease is neurodegenerative disease.